You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • T Cell Non-Hodgkin Lymphoma
  • +3 more
  • AUTO4
  • Barcelona, Spain
  • +4 more
2022-02-01
Feb 1, 2022
F
Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +20 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-24
Jan 24, 2022
B
Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Antigen-Escalation Stage
  • +3 more
  • Houston, Texas
  • +1 more
2022-02-04
Feb 4, 2022
T
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
2021-10-04
Oct 4, 2021
C
Recruiting
  • Refractory Non-Hodgkin Lymphoma
  • +8 more
  • San Francisco, California
    University of California, San Francisco
2021-08-20
Aug 20, 2021
P
Not yet recruiting
  • T-cell Non-Hodgkin's Lymphoma
  • CD147- CAR T cells
  • (no location specified)
2021-08-18
Aug 18, 2021
F
Completed
  • CD19-Positive Neoplastic Cells Present
  • +12 more
  • Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-08
Feb 8, 2022
P
Recruiting
  • B Cell Non-Hodgkin's Lymphoma
  • CD19/CD20-directed Chimeric Antigen Receptor T Cells
  • Beijing, China
    Peking University Cancer Hospital
2021-11-24
Nov 24, 2021
2
Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • bbT369
  • Denver, Colorado
  • +1 more
2022-02-10
Feb 10, 2022
T
Recruiting
  • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
  • Chimeric Antigen Receptor T Cells (CAR-T) Targeting Igβ Targets
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2022-04-03
Apr 3, 2022
B
Recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • Fully human anti CD19 CAR-T Cell Dose
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
2022-03-10
Mar 10, 2022
H
Recruiting
  • SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
  • Senl-T7
  • Beijing, Hebei, China
    Hebei yanda Ludaopei Hospital
2021-06-23
Jun 23, 2021
B
Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • CD19.CAR-CD28Z T Cells - dose escalation 2
  • CD19.CAR-CD28Z T Cells - dose escalation 1
  • Houston, Texas
  • +1 more
2022-02-10
Feb 10, 2022
M
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +8 more
  • 19(T2)28z1xx CAR T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-02-08
Feb 8, 2022
F
Recruiting
  • T-Acute Lymphoblastic Leukemia
  • +2 more
  • ThisCART7 cells
  • Hefei, Anhui, China
  • +1 more
2021-11-09
Nov 9, 2021
C
Recruiting
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Relapsed B-cell Non-Hodgkin Lymphoma
  • CAR-CD19 T Cells
  • Shanghai, Shanghai, China
  • +1 more
2020-10-07
Oct 7, 2020
U
Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • CAR.CD30 T cells
  • Chapel Hill, North Carolina
  • +2 more
2022-03-16
Mar 16, 2022
I
Recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • Peripheral T Cell Lymphoma (PTCL)
  • Ex-vivo expanded allogeneic γδT cells
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Disease Hospital
2021-01-05
Jan 5, 2021
M
Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
2021-04-30
Apr 30, 2021
F
Recruiting
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • +16 more
  • Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-03
Jan 3, 2022
H
Not yet recruiting
  • Relapsed and Refractory
  • Lymphoid Hematological Malignancies
  • GC022F CAR-T cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
2020-11-07
Nov 7, 2020
I
Recruiting
  • Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Autologous CAR19 T lymphocytes
  • Prague, Czechia
    Institute of Hematology and Blood Transfusion, Czech Republic
2021-09-13
Sep 13, 2021
H
Recruiting
  • Refractory Indolent Adult Non-Hodgkin Lymphoma
  • CD19 CAR-T
  • +4 more
  • Shijiazhuang, Hebei, China
    No.2 Hospital of Hebei Medical University
2020-11-11
Nov 11, 2020
W
Recruiting
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Duarte, California
  • +4 more
2022-03-30
Mar 30, 2022